AESI Atlas Energy Solutions | $12.25 -1.8% | 9/28/2026 | | Upgrade | $10.00 ➝ $14.00 | Underweight ➝ Equal Weight | 00.00% | View details for Barclays rating of Atlas Energy Solutions (NYSE:AESI) on 9/28/2026 |
KIM Kimco Realty | $22.47 +0.1% | 9/28/2026 | | Lower Price Target | $28.00 ➝ $27.00 | Overweight | 00.00% | View details for Barclays rating of Kimco Realty (NYSE:KIM) on 9/28/2026 |
LBRT Liberty Energy | $18.95 +0.0% | 9/28/2026 | | Upgrade | $27.00 | Equal Weight ➝ Overweight | 00.00% | View details for Barclays rating of Liberty Energy (NYSE:LBRT) on 9/28/2026 |
SKT Tanger | $34.74 +0.0% | 9/28/2026 | | Lower Price Target | $42.00 ➝ $41.00 | Equal Weight | 00.00% | View details for Barclays rating of Tanger (NYSE:SKT) on 9/28/2026 |
SNPS Synopsys | $417.61 -1.9% | 9/25/2026 | | Initiated Coverage | | Overweight | 00.00% | View details for Barclays rating of Synopsys (NASDAQ:SNPS) on 9/25/2026 |
HUM Humana | $389.91 -2.0% | 9/25/2026 | | Upgrade | $407.00 ➝ $515.00 | Equal Weight ➝ Overweight | 00.00% | View details for Barclays rating of Humana (NYSE:HUM) on 9/25/2026 |
GIS General Mills | $33.62 -0.1% | 9/25/2026 | | Boost Price Target | $36.00 ➝ $37.00 | Equal Weight | 00.00% | View details for Barclays rating of General Mills (NYSE:GIS) on 9/25/2026 |
P Everpure | $129.41 +2.7% | 9/25/2026 | | Boost Price Target | $110.00 ➝ $132.00 | Equal Weight | 00.00% | View details for Barclays rating of Everpure (NYSE:P) on 9/25/2026 |
CRL Charles River Laboratories International | $294.85 +0.7% | 9/25/2026 | | Boost Price Target | $300.00 ➝ $330.00 | Overweight | 00.00% | View details for Barclays rating of Charles River Laboratories International (NYSE:CRL) on 9/25/2026 |
GWW W.W. Grainger | $1,255.48 +1.0% | 9/25/2026 | | Lower Price Target | $1,185.00 ➝ $1,172.00 | Underweight | 00.00% | View details for Barclays rating of W.W. Grainger (NYSE:GWW) on 9/25/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
LGND Ligand Pharmaceuticals | $314.10 +4.2% | 9/25/2026 | | Initiated Coverage | $345.00 | Overweight | 00.00% | View details for Barclays rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 9/25/2026 |
ONON ON | $29.98 +0.1% | 9/24/2026 | | Boost Price Target | $42.00 ➝ $44.00 | Overweight | 00.00% | View details for Barclays rating of ON (NYSE:ONON) on 9/24/2026 |
OKTA Okta | $202.18 +3.6% | 9/24/2026 | | Boost Price Target | $180.00 ➝ $215.00 | Overweight | 00.00% | View details for Barclays rating of Okta (NASDAQ:OKTA) on 9/24/2026 |
FCEL FuelCell Energy | $16.14 -2.1% | 9/24/2026 | | Initiated Coverage | $20.00 | Equal Weight | 00.00% | View details for Barclays rating of FuelCell Energy (NASDAQ:FCEL) on 9/24/2026 |
NKE NIKE | $36.40 +1.8% | 9/23/2026 | | Reiterated Rating | $52.00 ➝ $48.00 | Overweight | 00.00% | View details for Barclays rating of NIKE (NYSE:NKE) on 9/23/2026 |
AZO AutoZone | $2,917.83 +1.6% | 9/23/2026 | | Lower Price Target | $3,637.00 ➝ $3,400.00 | Overweight | 00.00% | View details for Barclays rating of AutoZone (NYSE:AZO) on 9/23/2026 |
KBH KB Home | $47.88 -0.3% | 9/23/2026 | | Lower Price Target | $57.00 ➝ $49.00 | Overweight | 00.00% | View details for Barclays rating of KB Home (NYSE:KBH) on 9/23/2026 |
ABVX Abivax | $96.85 +6.4% | 9/22/2026 | | Reiterated Rating | $148.00 | Overweight | 00.00% | View details for Barclays rating of Abivax (NASDAQ:ABVX) on 9/22/2026 |
DRVN Driven Brands | $11.76 -4.5% | 9/22/2026 | | Initiated Coverage | $14.00 | Equal Weight | 00.00% | View details for Barclays rating of Driven Brands (NASDAQ:DRVN) on 9/22/2026 |
STZ Constellation Brands | $112.87 -0.7% | 9/22/2026 | | Lower Price Target | $132.00 ➝ $122.00 | Equal Weight | 00.00% | View details for Barclays rating of Constellation Brands (NYSE:STZ) on 9/22/2026 |
PAGP Plains GP | $26.60 +0.1% | 9/21/2026 | | Boost Price Target | $23.00 ➝ $24.00 | Underweight | 00.00% | View details for Barclays rating of Plains GP (NYSE:PAGP) on 9/21/2026 |
PAA Plains All American Pipeline | $24.53 +0.5% | 9/21/2026 | | Boost Price Target | $23.00 ➝ $24.00 | Underweight | 00.00% | View details for Barclays rating of Plains All American Pipeline (NASDAQ:PAA) on 9/21/2026 |
CDW CDW | $130.33 -3.8% | 9/21/2026 | | Lower Price Target | $150.00 ➝ $148.00 | Equal Weight | 00.00% | View details for Barclays rating of CDW (NASDAQ:CDW) on 9/21/2026 |
RARE Ultragenyx Pharmaceutical | $14.41 -0.6% | 9/21/2026 | | Boost Price Target | $32.00 ➝ $35.00 | Overweight | 00.00% | View details for Barclays rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 9/21/2026 |
LEN Lennar | $82.07 -0.1% | 9/18/2026 | | Lower Price Target | $79.00 ➝ $70.00 | Underweight | 00.00% | View details for Barclays rating of Lennar (NYSE:LEN) on 9/18/2026 |
HQY HealthEquity | $88.44 +0.2% | 9/18/2026 | | Boost Price Target | $110.00 ➝ $115.00 | Overweight | 00.00% | View details for Barclays rating of HealthEquity (NASDAQ:HQY) on 9/18/2026 |
TSEM Tower Semiconductor | $226.04 -1.9% | 9/18/2026 | | Initiated Coverage | $310.00 | Overweight | 00.00% | View details for Barclays rating of Tower Semiconductor (NASDAQ:TSEM) on 9/18/2026 |
HELP Cybin | $12.59 -0.2% | 9/18/2026 | | Initiated Coverage | $35.00 | Overweight | 00.00% | View details for Barclays rating of Cybin (NASDAQ:HELP) on 9/18/2026 |
TSEM Tower Semiconductor | $226.04 -1.9% | 9/18/2026 | | Initiated Coverage | $310.00 | Overweight | 00.00% | View details for Barclays rating of Tower Semiconductor (NASDAQ:TSEM) on 9/18/2026 |
OSCR Oscar Health | $29.69 +0.3% | 9/17/2026 | | Boost Price Target | $39.00 ➝ $49.00 | Overweight | 00.00% | View details for Barclays rating of Oscar Health (NYSE:OSCR) on 9/17/2026 |
IOVA Iovance Biotherapeutics | $10.99 -0.1% | 9/17/2026 | | Boost Price Target | $13.00 ➝ $15.00 | Overweight | 00.00% | View details for Barclays rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 9/17/2026 |
AMRX Amneal Pharmaceuticals | $20.50 +3.7% | 9/17/2026 | | Boost Price Target | $16.00 ➝ $20.00 | Overweight | 00.00% | View details for Barclays rating of Amneal Pharmaceuticals (NASDAQ:AMRX) on 9/17/2026 |
PSKY Paramount Skydance | $10.28 +3.2% | 9/17/2026 | | Initiated Coverage | $8.00 | Underweight | 00.00% | View details for Barclays rating of Paramount Skydance (NASDAQ:PSKY) on 9/17/2026 |
CIEN Ciena | $343.71 -3.7% | 9/17/2026 | | Boost Price Target | $475.00 ➝ $548.00 | Overweight | 00.00% | View details for Barclays rating of Ciena (NYSE:CIEN) on 9/17/2026 |
IPSEY IPSEN | $40.89 -2.6% | 9/17/2026 | | Upgrade | | Strong Sell ➝ Hold | 00.00% | View details for Barclays rating of IPSEN (OTCMKTS:IPSEY) on 9/17/2026 |
PSKY Paramount Skydance | $10.28 +3.2% | 9/17/2026 | | Initiated Coverage | $8.00 | Underweight | 00.00% | View details for Barclays rating of Paramount Skydance (NASDAQ:PSKY) on 9/17/2026 |
TSEM Tower Semiconductor | $226.04 -1.9% | 9/17/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Barclays rating of Tower Semiconductor (NASDAQ:TSEM) on 9/17/2026 |
WBD Warner Bros. Discovery | $30.90 +0.1% | 9/17/2026 | | Initiated Coverage | $29.00 | Equal Weight | 00.00% | View details for Barclays rating of Warner Bros. Discovery (NASDAQ:WBD) on 9/17/2026 |
INTC Intel | $116.03 -5.7% | 9/16/2026 | | Upgrade | | Hold ➝ Overweight | 00.00% | View details for Barclays rating of Intel (NASDAQ:INTC) on 9/16/2026 |
JBHT J.B. Hunt Transport Services | $226.07 +0.3% | 9/16/2026 | | Lower Price Target | $300.00 ➝ $285.00 | Equal Weight | 00.00% | View details for Barclays rating of J.B. Hunt Transport Services (NASDAQ:JBHT) on 9/16/2026 |
If you keep cash in a U.S. bank account… read this NOW (Ad) Since 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every dollar while paying savers just 0.04 percent interest.
A new law, the GENIUS Act signed last summer, has cleared the way for a different kind of money to emerge this fall, one that could offer savings rates up to 6 percent.
See what Ian King, Chief Strategist at Strategic Fortunes, has uncovered about this shift before it goes live. Click here to see what Ian King found about this new savings shift |
CCL Carnival | $22.15 -0.4% | 9/16/2026 | | Lower Price Target | $35.00 ➝ $33.00 | Overweight | 00.00% | View details for Barclays rating of Carnival (NYSE:CCL) on 9/16/2026 |
TARS Tarsus Pharmaceuticals | $76.81 +1.5% | 9/16/2026 | | Initiated Coverage | $110.00 | Overweight | 00.00% | View details for Barclays rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 9/16/2026 |
CLLS Cellectis | $1.48 +0.7% | 9/16/2026 | | Downgrade | $9.00 ➝ $1.30 | Overweight ➝ Underweight | 00.00% | View details for Barclays rating of Cellectis (NASDAQ:CLLS) on 9/16/2026 |
ALVO Alvotech | $6.15 +7.0% | 9/16/2026 | | Upgrade | $4.00 ➝ $8.00 | Underweight ➝ Overweight | 00.00% | View details for Barclays rating of Alvotech (NASDAQ:ALVO) on 9/16/2026 |
TARS Tarsus Pharmaceuticals | $76.81 +1.5% | 9/16/2026 | | Reiterated Rating | $110.00 | Overweight | 00.00% | View details for Barclays rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 9/16/2026 |
FTAI FTAI Aviation | $167.10 -4.5% | 9/15/2026 | | Lower Price Target | $350.00 ➝ $310.00 | Overweight | 00.00% | View details for Barclays rating of FTAI Aviation (NASDAQ:FTAI) on 9/15/2026 |
BANC Banc of California | $17.69 -1.4% | 9/15/2026 | | Set Price Target | $10.00 | | 00.00% | View details for Barclays rating of Banc of California (NYSE:BANC) on 9/15/2026 |
MSTR Strategy | $157.14 -0.9% | 9/15/2026 | | Reiterated Rating | $125.00 ➝ $160.00 | Overweight | 00.00% | View details for Barclays rating of Strategy (NASDAQ:MSTR) on 9/15/2026 |
BKV BKV | $21.87 +0.3% | 9/15/2026 | | Lower Price Target | $36.00 ➝ $35.00 | Overweight | 00.00% | View details for Barclays rating of BKV (NYSE:BKV) on 9/15/2026 |
SRRK Scholar Rock | $49.13 +1.0% | 9/15/2026 | | Downgrade | | Overweight ➝ Cautious | 00.00% | View details for Barclays rating of Scholar Rock (NASDAQ:SRRK) on 9/15/2026 |
WAY Waystar | $25.74 +4.2% | 9/15/2026 | | Downgrade | $27.00 ➝ $30.00 | Overweight ➝ Equal Weight | 00.00% | View details for Barclays rating of Waystar (NASDAQ:WAY) on 9/15/2026 |
SRRK Scholar Rock | $49.13 +1.0% | 9/14/2026 | | Reiterated Rating | $55.00 ➝ $58.00 | Overweight ➝ Equal Weight | 00.00% | View details for Barclays rating of Scholar Rock (NASDAQ:SRRK) on 9/14/2026 |
ZIM ZIM Integrated Shipping Services | $28.47 -2.5% | 9/14/2026 | | Set Price Target | $30.00 | Underweight ➝ Equal Weight | 00.00% | View details for Barclays rating of ZIM Integrated Shipping Services (NYSE:ZIM) on 9/14/2026 |
ZIM ZIM Integrated Shipping Services | $28.47 -2.5% | 9/14/2026 | | Upgrade | $30.00 | Underweight ➝ Equal Weight | 00.00% | View details for Barclays rating of ZIM Integrated Shipping Services (NYSE:ZIM) on 9/14/2026 |
ORCL Oracle | $132.64 -3.3% | 9/11/2026 | | Boost Price Target | $250.00 ➝ $252.00 | Overweight | 00.00% | View details for Barclays rating of Oracle (NYSE:ORCL) on 9/11/2026 |
OMDA Omada Health | $19.39 -1.4% | 9/11/2026 | | Boost Price Target | $25.00 ➝ $27.00 | Overweight | 00.00% | View details for Barclays rating of Omada Health (NASDAQ:OMDA) on 9/11/2026 |
XNCR Xencor | $25.60 +7.6% | 9/11/2026 | | Boost Price Target | $27.00 ➝ $35.00 | Overweight | 00.00% | View details for Barclays rating of Xencor (NASDAQ:XNCR) on 9/11/2026 |
MNPR Monopar Therapeutics | $83.72 -1.8% | 9/11/2026 | | Reiterated Rating | $128.00 ➝ $145.00 | Overweight | 00.00% | View details for Barclays rating of Monopar Therapeutics (NASDAQ:MNPR) on 9/11/2026 |
LEGN Legend Biotech | $18.62 -2.6% | 9/11/2026 | | Lower Price Target | $78.00 ➝ $74.00 | Overweight | 00.00% | View details for Barclays rating of Legend Biotech (NASDAQ:LEGN) on 9/11/2026 |
LH Labcorp | $309.85 +0.1% | 9/11/2026 | | Boost Price Target | $320.00 ➝ $330.00 | Equal Weight | 00.00% | View details for Barclays rating of Labcorp (NYSE:LH) on 9/11/2026 |
UAL United Airlines | $111.51 -2.2% | 9/11/2026 | | Lower Price Target | $175.00 ➝ $160.00 | Overweight | 00.00% | View details for Barclays rating of United Airlines (NASDAQ:UAL) on 9/11/2026 |
ULCC Frontier Group | $6.08 -1.8% | 9/11/2026 | | Lower Price Target | $7.00 ➝ $5.00 | Underweight | 00.00% | View details for Barclays rating of Frontier Group (NASDAQ:ULCC) on 9/11/2026 |
DAL Delta Air Lines | $84.00 -1.1% | 9/11/2026 | | Lower Price Target | $105.00 ➝ $95.00 | Overweight | 00.00% | View details for Barclays rating of Delta Air Lines (NYSE:DAL) on 9/11/2026 |
AAL American Airlines Group | $13.52 -2.5% | 9/11/2026 | | Lower Price Target | $19.00 ➝ $14.00 | Equal Weight | 00.00% | View details for Barclays rating of American Airlines Group (NASDAQ:AAL) on 9/11/2026 |
ALGT Allegiant Travel | $76.55 -3.2% | 9/11/2026 | | Lower Price Target | $145.00 ➝ $115.00 | Overweight | 00.00% | View details for Barclays rating of Allegiant Travel (NASDAQ:ALGT) on 9/11/2026 |
ALK Alaska Air Group | $39.68 -3.1% | 9/11/2026 | | Set Price Target | $65.00 ➝ $52.00 | Overweight | 00.00% | View details for Barclays rating of Alaska Air Group (NYSE:ALK) on 9/11/2026 |
JBLU JetBlue Airways | $4.22 -4.1% | 9/11/2026 | | Lower Price Target | $7.00 ➝ $5.00 | Equal Weight | 00.00% | View details for Barclays rating of JetBlue Airways (NASDAQ:JBLU) on 9/11/2026 |
LUV Southwest Airlines | $42.26 -1.0% | 9/11/2026 | | Lower Price Target | $65.00 ➝ $58.00 | Overweight | 00.00% | View details for Barclays rating of Southwest Airlines (NYSE:LUV) on 9/11/2026 |
AEO American Eagle Outfitters | $17.26 +4.1% | 9/10/2026 | | Lower Price Target | $17.00 ➝ $15.00 | Equal Weight | 00.00% | View details for Barclays rating of American Eagle Outfitters (NYSE:AEO) on 9/10/2026 |
PSA Public Storage | $284.84 -1.1% | 9/10/2026 | | Boost Price Target | $350.00 ➝ $351.00 | Equal Weight | 00.00% | View details for Barclays rating of Public Storage (NYSE:PSA) on 9/10/2026 |
CNM Core & Main | $42.44 -0.5% | 9/10/2026 | | Lower Price Target | $62.00 ➝ $61.00 | Overweight | 00.00% | View details for Barclays rating of Core & Main (NYSE:CNM) on 9/10/2026 |
JAZZ Jazz Pharmaceuticals | $238.28 +0.1% | 9/10/2026 | | Boost Price Target | $270.00 ➝ $271.00 | Overweight | 00.00% | View details for Barclays rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 9/10/2026 |
ONC BeOne Medicines | $367.00 +1.7% | 9/10/2026 | | Boost Price Target | $407.00 ➝ $415.00 | Overweight | 00.00% | View details for Barclays rating of BeOne Medicines (NASDAQ:ONC) on 9/10/2026 |
ASO Academy Sports and Outdoors | $48.61 -1.1% | 9/10/2026 | | Boost Price Target | $50.00 ➝ $53.00 | Equal Weight | 00.00% | View details for Barclays rating of Academy Sports and Outdoors (NASDAQ:ASO) on 9/10/2026 |
LFST LifeStance Health Group | $11.84
| 9/10/2026 | | Boost Price Target | $13.00 ➝ $15.00 | Overweight | 00.00% | View details for Barclays rating of LifeStance Health Group (NASDAQ:LFST) on 9/10/2026 |
SAIL SailPoint | $20.57 -0.3% | 9/10/2026 | | Boost Price Target | $21.00 ➝ $22.00 | Overweight | 00.00% | View details for Barclays rating of SailPoint (NASDAQ:SAIL) on 9/10/2026 |
SFD Smithfield Foods | $19.14 +0.5% | 9/9/2026 | | Lower Price Target | $31.00 ➝ $29.00 | Overweight | 00.00% | View details for Barclays rating of Smithfield Foods (NASDAQ:SFD) on 9/9/2026 |
IONS Ionis Pharmaceuticals | $45.57 +2.4% | 9/9/2026 | | Lower Price Target | $90.00 ➝ $85.00 | Overweight | 00.00% | View details for Barclays rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 9/9/2026 |
QCOM Qualcomm | $187.48 -7.2% | 9/9/2026 | | Reiterated Rating | | Underweight | 00.00% | View details for Barclays rating of Qualcomm (NASDAQ:QCOM) on 9/9/2026 |
SGMT Sagimet Biosciences | $9.94 +7.6% | 9/9/2026 | | Upgrade | $8.00 ➝ $18.00 | Equal Weight ➝ Overweight | 00.00% | View details for Barclays rating of Sagimet Biosciences (NASDAQ:SGMT) on 9/9/2026 |
CHYM Chime Financial | $26.69 -0.3% | 9/9/2026 | | Boost Price Target | $33.00 ➝ $40.00 | Overweight | 00.00% | View details for Barclays rating of Chime Financial (NASDAQ:CHYM) on 9/9/2026 |
VRSK Verisk Analytics | $167.77 -0.9% | 9/8/2026 | | Lower Price Target | $275.00 ➝ $225.00 | Overweight | 00.00% | View details for Barclays rating of Verisk Analytics (NASDAQ:VRSK) on 9/8/2026 |
IRM Iron Mountain | $110.87 -0.5% | 9/8/2026 | | Boost Price Target | $143.00 ➝ $144.00 | Overweight | 00.00% | View details for Barclays rating of Iron Mountain (NYSE:IRM) on 9/8/2026 |
EQIX Equinix | $1,011.07 +0.3% | 9/8/2026 | | Boost Price Target | $1,130.00 ➝ $1,135.00 | Equal Weight | 00.00% | View details for Barclays rating of Equinix (NASDAQ:EQIX) on 9/8/2026 |
DG Dollar General | $124.50 -0.3% | 9/8/2026 | | Boost Price Target | $148.00 ➝ $151.00 | Overweight | 00.00% | View details for Barclays rating of Dollar General (NYSE:DG) on 9/8/2026 |
SNX TD SYNNEX | $256.29 -2.6% | 9/8/2026 | | Boost Price Target | $278.00 ➝ $287.00 | Equal Weight | 00.00% | View details for Barclays rating of TD SYNNEX (NYSE:SNX) on 9/8/2026 |
MANH Manhattan Associates | $201.88 -2.0% | 9/8/2026 | | Boost Price Target | $201.00 ➝ $239.00 | Overweight | 00.00% | View details for Barclays rating of Manhattan Associates (NASDAQ:MANH) on 9/8/2026 |
CDW CDW | $130.33 -3.8% | 9/8/2026 | | Boost Price Target | $123.00 ➝ $150.00 | Equal Weight | 00.00% | View details for Barclays rating of CDW (NASDAQ:CDW) on 9/8/2026 |
APH Amphenol | $84.55 +0.5% | 9/8/2026 | | Reiterated Rating | $200.00 ➝ $100.00 | Overweight | 00.00% | View details for Barclays rating of Amphenol (NYSE:APH) on 9/8/2026 |
JBTM JBT Marel | $111.30 +1.1% | 9/8/2026 | | Initiated Coverage | $150.00 | Overweight | 00.00% | View details for Barclays rating of JBT Marel (NYSE:JBTM) on 9/8/2026 |
Here’s the stock symbol I’ve promised (Ad) Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better.
This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required. Get the stock name and ticker symbol free of charge today |
IPSEY IPSEN | $40.89 -2.6% | 9/8/2026 | | Downgrade | | Equal Weight ➝ Underweight | 00.00% | View details for Barclays rating of IPSEN (OTCMKTS:IPSEY) on 9/8/2026 |
FDS FactSet Research Systems | $267.61 -2.0% | 9/8/2026 | | Boost Price Target | $216.00 ➝ $250.00 | Underweight | 00.00% | View details for Barclays rating of FactSet Research Systems (NYSE:FDS) on 9/8/2026 |
HKMPF Hikma Pharmaceuticals | $21.10
| 9/8/2026 | | Upgrade | | Strong Sell ➝ Hold | 00.00% | View details for Barclays rating of Hikma Pharmaceuticals (OTCMKTS:HKMPF) on 9/8/2026 |
JBTM JBT Marel | $111.30 +1.1% | 9/8/2026 | | Initiated Coverage | $150.00 | Overweight | 00.00% | View details for Barclays rating of JBT Marel (NYSE:JBTM) on 9/8/2026 |
RRC Range Resources | $37.87 -1.9% | 9/8/2026 | | Boost Price Target | $40.00 ➝ $42.00 | Equal Weight | 00.00% | View details for Barclays rating of Range Resources (NYSE:RRC) on 9/8/2026 |
SLG SL Green Realty | $49.28 -3.4% | 9/8/2026 | | Boost Price Target | $52.00 ➝ $54.00 | Equal Weight | 00.00% | View details for Barclays rating of SL Green Realty (NYSE:SLG) on 9/8/2026 |
SYM Symbotic | $42.00 -3.4% | 9/8/2026 | | Lower Price Target | $44.00 ➝ $38.00 | Underweight | 00.00% | View details for Barclays rating of Symbotic (NASDAQ:SYM) on 9/8/2026 |
TRI Thomson Reuters | $97.33 -1.7% | 9/8/2026 | | Lower Price Target | $140.00 ➝ $130.00 | Overweight | 00.00% | View details for Barclays rating of Thomson Reuters (NASDAQ:TRI) on 9/8/2026 |
ZLDPF Zealand Pharma A/S | $41.99
| 9/8/2026 | | Downgrade | | Strong-Buy ➝ Hold | 00.00% | View details for Barclays rating of Zealand Pharma A/S (OTCMKTS:ZLDPF) on 9/8/2026 |
ASOMY Asos Pls | $6.54 +0.7% | 9/7/2026 | | Upgrade | | Strong Sell ➝ Hold | 00.00% | View details for Barclays rating of Asos Pls (OTCMKTS:ASOMY) on 9/7/2026 |